close

Enter

Log in using OpenID

Drug of Abuse Testing Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 2019 to 2029

embed
A considerable rise in cases of drug abuse due to opium dependency and confusion between CBD based medical marijuana and marijuana that creates a high is emphasizing the need for drug abuse testing. Increase in mortality rate due to drug abuse is ca
Drug of Abuse Testing Market Global Trends, Market Share, Industry Size, Growth,
Opportunities, and Market Forecast 2019 to 2029
A considerable rise in cases of drug abuse due to opium dependency and confusion
between CBD based medical marijuana and marijuana that creates a high is
emphasizing the need for drug abuse testing. Increase in mortality rate due to drug
abuse is causing the governments to impose strict regulations to make drug of abuse
tests mandatory for employment, criminal justice cases and protection for social
causes. Besides the advancements in test equipment technology that facilitate quick
and ultrasensitive detections of newly formulated abusive drugs. Above mentioned
the market stimulants causing a significant upsurge in the global drug of abuse
testing market.
The global drug of abuse testing market is to triumph with fabulous global market
value overpassing $11 billion marks by 2026 end and registering a CAGR of 7.3%
during the forecast period from 2019 to 2026.
Substance Abuse and Mental Health Services Administration (SAMHSA) guidelines
govern the collection criteria, a database about companies conducting employment
screening, the test that cleared over-the-counter use, specimen testing of
substituted or diluted drugs that are habit-forming, whereas FDA regulates drugs of
abuse tests mainly by reviewing the design and performance of tests that are widely
sold to consumers and healthcare professionals. The drug of abuse tests
manufacturers equipped with insights to updated data submitted to SAMSHA and
the FDA would be able to fare well in the market.
Request a Sample Report @ https://www.futurewiseresearch.com/requestsample.aspx?id=12&page=requestsample
Restraints Hampering the Growth of Drug of Abuse Testing Market
• Shortage of experienced technicians for the drug of abuse testing
• Issues with privacy rights in certain countries
• The inability of tests to detect abusive drugs designed with non-detectable traces
of forbidden substances.
Global Drug of Abuse Testing, by Test Type:
• Immunoassay Test
• Point-of-Care Tests
• Chromatography Tests
The prominence of most common, quick and inexpensive drug screening test
preferred for initial screening is reserved by immunoassay tests and hence hold a key
share in the drug of abuse testing market. As the need for portable consumer-centric
convenient diagnosis is gaining traction, point-of-care tests segment is estimated to
grow at a lucrative CARG in the near future.
Global Drug of Abuse Testing, by Sample Type:
• Urine
• Blood
• Saliva
Global Drug of Abuse Testing, by End User:
• Pathology Laboratories
• Hospitals
• Rehabilitation Centers
• Federal Agencies
• Forensic Laboratories
• Clinics
• Others
Global Drug of Abuse Testing, by Region:
• Europe
• North America
• APAC
• Latin America
• Rest of World
North America market witnessed significant share due to stringent federal policies. It
was followed by the European drug of abuse testing market with stable market
growth over the forecast period. The Europe market is poised to value over $ 4
billion by the end of 2026. The Asia Pacific and Latin America to witness the fastest
CAGR due to increasing awareness.
Purchase a Copy & Ask For Discount: https://www.futurewiseresearch.com/requestsample.aspx?id=12&page=askfordiscount
Competitive Landscape:
• Tier 1 players- established companies in the market with major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants
FutureWise Takeaways
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points
Objectives of the Study:
• To provide with an exhaustive analysis on the global drug of abuse testing market
on the basis of test type, sample type, end-user and region
• To cater comprehensive information on factors impacting market growth (drivers,
restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and overall market
• To predict market size, in five key regions (along with countries)—North America,
Europe, Asia Pacific, Latin America, and the Middle East
• To record evaluate and competitive landscape mapping- product launches,
technological advancements, mergers and expansions
• Profiling of companies to evaluate their market shares, strategies, financials and
core competencies
Table of Contents
1. Introduction
1.1. Scope and Objective
1.2. Assumptions and Acronyms
1.3. Forecast Factors
1.4. Research Methodology
2.
Executive Summary
2.1. Industry Cluster Analysis
2.2. Competition Matrix
2.3. Strategies Recommendations
3. Market Definition
3.1. Report Scope (Inclusions & Exclusions)
3.2. Market Segmentation
4.
Global Drug of Abuse Testing Market Overview
4.1. Global Drug of Abuse Testing Market Revenue (USD Mn)
5.
Key Inclusions
5.1. Porter’s Five Force analysis
5.2. Market Dynamics
5.3. Industry Trends
5.4. Regulatory Guidelines
5.5. Opportunities in Drug of Abuse Testing
6.
Competition Dynamics
6.1. Company Share Analysis (2018)
6.2. Top 10 Product Pricing by Region
7. Global Drug of Abuse Testing Market Revenue (USD Mn), 2018-2026 by Test
Type
7.1. Key Market Findings
7.2. Long Term ROI Segments
7.3. Revenue Opportunity Influencing Factors
7.4. Market Revenue (USD Mn) Assessment and Forecast by Test Type, 2018-2026
7.4.1
Immunoassay Test
7.4.2
POCT Tests
7.4.3
Chromatography Tests
7.4.4
Academic Institutes
8. Global Drug of Abuse Testing Market Revenue (USD Mn), 2018-2026 by Sample
Type
8.1. Key Market Findings
8.2. Long Term ROI Segments
8.3.
Revenue Opportunity Influencing Factors
8.4. Market Revenue (USD Mn) Assessment and Forecast by Sample
Type, 2018-2026
8.4.1
Urine
8.4.2
Saliva
8.4.3
Blood
8.4.4
Others
9. Global Drug of Abuse Testing Market Revenue (USD Mn), 2018-2026 by End
User
9.1. Key Market Findings
9.2. Long Term ROI Segments
9.3.
Revenue Opportunity Influencing Factors
9.4. Market Revenue (USD Mn) Assessment and Forecast by End User, 20182026
9.4.1
Pathology Laboratories
9.4.2
Hospitals
9.4.3
Rehabilitation Centres
9.4.4
Federal Agencies
9.4.5
Forensic Laboratories
9.4.6
Clinics
9.4.7
Others
10. Global Drug of Abuse Testing Market Revenue (USD Mn), 2018-2026 by Region
10.1.Key Market Findings
10.2.Long Term ROI Segments
10.3.Revenue Opportunity Influencing Factors
10.4.Market Revenue (USD Mn) Assessment and Forecast by Region,2026
10.4.1 North America
10.4.2 Latin America
10.4.3 Europe
10.4.4 Asia Pacific
10.4.5 Rest of world
11. North America Drug of Abuse Testing Market Revenue (US$ Mn), 2018-2026
11.1. Key Market Findings
11.2. Long Term ROI Segments
11.3. Revenue Opportunity Influencing Factors
11.4. Market Revenue (USD Mn) Assessment and Forecast by Country,
2018-2026
11.4.1 US
11.4.2 Canada
11.5. Market Revenue (USD Mn) Assessment and Forecast by Test Type,
2018-2026
11.5.3 Immunoassay Test
11.5.4 POCT Tests
11.5.5 Chromatography Tests
11.5.6 Academic Institutes
11.6. Market Revenue (USD Mn) Assessment and Forecast by Sample
Type, 2018-2026
11.6.7 Urine
11.6.8 Saliva
11.6.9 Blood
11.6.10 Others
11.7. Market Revenue (USD Mn) Assessment and Forecast by End User,
2018-2026
11.7.11 Pathology Laboratories
11.7.12 Hospitals
11.7.13 Rehabilitation Centres
11.7.14 Federal Agencies
11.7.15 Forensic Laboratories
11.7.16 Clinics
11.7.17 Others
12. Latin America Drug of Abuse Testing Market Revenue (US$ Mn), 2018-2026
12.1. Key Market Findings
12.2. Long Term ROI Segments
12.3. Revenue Opportunity Influencing Factors
12.4. Market Revenue (USD Mn) Assessment and Forecast by Country,
2018-2026
12.4.1 Brazil
12.4.2 Mexico
12.4.3 Argentina
12.4.4 Rest of Latin America
12.5. Market Revenue (USD Mn) Assessment and Forecast by Test Type,
2018-2026
12.5.5 Immunoassay Test
12.5.6 POCT Tests
12.5.7 Chromatography Tests
12.5.8 Academic Institutes
12.6. Market Revenue (USD Mn) Assessment and Forecast by Sample
Type, 2018-2026
12.6.9 Urine
12.6.10 Saliva
12.6.11Blood
12.6.12 Others
12.7. Market Revenue (USD Mn) Assessment and Forecast by End User,
2018-2026
12.7.13 Pathology Laboratories
12.7.14 Hospitals
12.7.15 Rehabilitation Centres
12.7.16 Federal Agencies
12.7.17 Forensic Laboratories
12.7.18 Clinics
12.7.19 Others
13. Europe America Drug of Abuse Testing Market Revenue (US$ Mn), 2018-2026
13.1. Key Market Findings
13.2. Long Term ROI Segments
13.3. Revenue Opportunity Influencing Factors
13.4. Market Revenue (USD Mn) Assessment and Forecast by Country,
2018-2026
13.4.1 Germany
13.4.2 France
13.4.3 Spain
13.4.4 UK
13.4.5 Russia
13.4.6 Poland
13.4.7 Rest of Europe
13.5. Market Revenue (USD Mn) Assessment and Forecast by Test Type,
2018-2026
13.5.8 Immunoassay Test
13.5.9 POCT Tests
13.5.10Chromatography Tests
13.5.11Academic Institutes
13.6. Market Revenue (USD Mn) Assessment and Forecast by Sample
Type, 2018-2026
13.6.12Urine
13.6.13Saliva
13.6.14Blood
13.6.15 Others
13.7. Market Revenue (USD Mn) Assessment and Forecast by End User,
2018-2026
13.7.16 Pathology Laboratories
13.7.17 Hospitals
13.7.18 Rehabilitation Centres
13.7.19 Federal Agencies
13.7.20 Forensic Laboratories
13.7.21 Clinics
13.7.22 Others
14. Asia Pacific America Drug of Abuse Testing Market Revenue (US$ Mn), 20182026
14.1. Key Market Findings
14.2. Long Term ROI Segments
14.3. Revenue Opportunity Influencing Factors
14.4. Market Revenue (USD Mn) Assessment and Forecast by Country,
2018-2026
14.4.1 Emerging Asia
14.4.1.1
China
14.4.1.2
India
14.4.1.3
ASEAN-5
14.4.1.4
Rest of Emerging Asia
14.4.2 Japan
14.5. Market Revenue (USD Mn) Assessment and Forecast by Test Type,
2018-2026
14.5.3 Immunoassay Test
14.5.4 POCT Tests
14.5.5 Chromatography Tests
14.5.6 Academic Institutes
14.6. Market Revenue (USD Mn) Assessment and Forecast by Sample
Type, 2018-2026
14.6.7 Urine
14.6.8 Saliva
14.6.9 Blood
14.6.10 Others
14.7. Market Revenue (USD Mn) Assessment and Forecast by End User,
2018-2026
14.7.11 Pathology Laboratories
14.7.12 Hospitals
14.7.13 Rehabilitation Centres
14.7.14 Federal Agencies
14.7.15 Forensic Laboratories
14.7.16 Clinics
14.7.17 Others
15. Rest of World America Drug of Abuse Testing Market Revenue (US$ Mn), 20182026
15.1. Key Market Findings
15.2. Long Term ROI Segments
15.3. Revenue Opportunity Influencing Factors
15.4. Market Revenue (USD Mn) Assessment and Forecast by Country,
2018-2026
15.4.1 Middle East
15.4.2 South Africa
15.4.3 North Africa
15.4.4 Rest of World
15.5. Market Revenue (USD Mn) Assessment and Forecast by Test Type,
2018-2026
15.5.5 Immunoassay Test
15.5.6 POCT Tests
15.5.7 Chromatography Tests
15.5.8 Academic Institutes
15.6. Market Revenue (USD Mn) Assessment and Forecast by Sample
Type, 2018-2026
15.6.9 Urine
15.6.10Saliva
15.6.11Blood
15.6.12 Others
15.7. Market Revenue (USD Mn) Assessment and Forecast by End User,
2018-2026
15.7.13 Pathology Laboratories
15.7.14 Hospitals
15.7.15 Rehabilitation Centres
15.7.16 Federal Agencies
15.7.17 Forensic Laboratories
15.7.18 Clinics
15.7.19 Others
16. Company Profiles
16.1. Competition Landscape
16.2. Global Company Share (USD Mn) Overview, 2018
16.3. Company Profiles
16.3.1 Thermo Fisher Scientific
16.3.1.1
Corporate Overview
16.3.1.2
Financial Performance
16.3.1.3
Peer Comparison & 3C marketing equation
16.3.1.4
Company Strategy & Channel Management
16.3.2 SYNLAB
16.3.2.1
Corporate Overview
16.3.2.2
Financial Performance
16.3.2.3
Peer Comparison & 3C marketing equation
16.3.2.4
Company Strategy & Channel Management
16.3.3 Siemens Healthcare Private Limited
16.3.3.1
Corporate Overview
16.3.3.2
Financial Performance
16.3.3.3
Peer Comparison & 3C marketing equation
16.3.3.4
Company Strategy & Channel Management
16.3.4 Roche Diagnostics
16.3.4.1
Corporate Overview
16.3.4.2
Financial Performance
16.3.4.3
Peer Comparison & 3C marketing equation
16.3.4.4
Company Strategy & Channel Management
16.3.5 Drägerwerk AG & Co. KGaA
16.3.5.1
Corporate Overview
16.3.5.2
Financial Performance
16.3.5.3
Peer Comparison & 3C marketing equation
16.3.5.4
Company Strategy & Channel Management
16.3.6 Beckman Coulter, Inc.
16.3.6.1
Corporate Overview
16.3.6.2
Financial Performance
16.3.6.3
Peer Comparison & 3C marketing equation
16.3.6.4
Company Strategy & Channel Management
16.3.7 Abbott Laboratories
16.3.7.1
Corporate Overview
16.3.7.2
Financial Performance
16.3.7.3
Peer Comparison & 3C marketing equation
16.3.7.4
Company Strategy & Channel Management
17. Research Sources & Primary Verbatim
Inquire further details about this report at: [email protected]
About FutureWise Research:
We specialise in high-growth niche markets, assuring flexibility, agility and
customised solutions for our clients. Through in-depth market insights and
consultancy, we present our clients with the tools they need to be at the forefront of
their industry – a position secured for far more than the near future.
Contact Us:
Company Name: FutureWise Research
Contact Person: Vinay Thaploo
Email: [email protected]
Phone: +44 141 628 9353 / +1 970 279 4295
City: Leeds
Country: United Kingdom
Website: www.futurewiseresearch.com
1/--pages
Report inappropriate content